Company
Headquarters: Taipei, Taiwan
TW$2.40 Billion
TWD as of Jan. 1, 2024
US$78.2 Million
Company | Market Cap (USD) |
---|---|
Abbott | $192.67 B |
Stryker Corporation | $113.24 B |
Medtronic | $111.60 B |
Boston Scientific Corporation | $85.22 B |
Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Diamond Biotechnology Co., Ltd engages in the research, development, manufacture, and sale of medical equipment and consumables. It offers medical beauty-level skin care products. The company also provides medical beauty management consultancy services. Its customers include hospitals, clinics, and open channels primarily in Taiwan. The company was founded in 2014 and is based in Taipei, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Diamond Biotechnology Co. Ltd has the following listings and related stock indices.
Stock: TWSE: 6815 wb_incandescent